Rchr
J-GLOBAL ID:202001007616549309   Update date: May. 13, 2024

Hata Kenichiro

Hata Kenichiro
Affiliation and department:
Research field  (1): Allergies and connective tissue disease
Research theme for competitive and other funds  (1):
  • 2016 - 2019 Elucidation of pathophysiological mechanism of interstitial pneumonia in dermatomyositis and biomarker mining for its therapeutic control
Papers (99):
  • Ryu Watanabe, Kosuke Ebina, Takaho Gon, Tadashi Okano, Koichi Murata, Kosaku Murakami, Yuichi Maeda, Sadao Jinno, Iku Shirasugi, Yonsu Son, et al. Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study. Rheumatology (Oxford, England). 2024
  • Kenichiro Hata, Takuya Kotani, Shogo Matsuda, Youhei Fujiki, Takayasu Suzuka, Takao Kiboshi, Yumiko Wada, Hideyuki Shiba, Takeshi Shoda, Maki Kagitani, et al. Aggressive multi-combination therapy for anti-MDA5 antibody-positive dermatomyositis-rapidly progressive interstitial lung disease. International journal of rheumatic diseases. 2024. 27. 1. e14999
  • Shogo Matsuda, Katsumasa Oe, Takuya Kotani, Ayana Okazaki, Takao Kiboshi, Takayasu Suzuka, Yumiko Wada, Hideyuki Shiba, Kenichiro Hata, Takeshi Shoda, et al. Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis. International journal of molecular sciences. 2023. 24. 19
  • Hideyuki Shiba, Takuya Kotani, Koji Nagai, Kenichiro Hata, Wataru Yamamoto, Ayaka Yoshikawa, Yumiko Wada, Yuri Hiramatsu, Hidehiko Makino, Yo Ueda, et al. Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by Pneumocystis jirovecii Pneumonia and One-Year Clinical Course: The ANSWER Cohort Study. International journal of molecular sciences. 2023. 24. 8
  • Hidehiko Makino, Takuya Kotani, Kenichiro Hata, Daisuke Nishioka, Wataru Yamamoto, Ayaka Yoshikawa, Yumiko Wada, Yuri Hiramatsu, Hideyuki Shiba, Koji Nagai, et al. Prognostic factors affecting respiratory-related death in patients with rheumatoid arthritis complicated by interstitial lung disease: An ANSWER cohort study. Modern rheumatology. 2022
more...
MISC (157):
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page